Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9135894 | 1.00 | KIF11 (0.67) | KIF11DNMT1 | |
| SCHEMBL3439368 | 0.87 | KIF11 (0.85) | KIF11DNMT1 | |
| SCHEMBL9137501 | 0.87 | KIF11 (0.85) | KIF11DNMT1 | |
| SCHEMBL12872399 | 0.87 | KIF11 (0.85) | KIF11DNMT1 | |
| SCHEMBL15662531 | 0.85 | KIF11 (0.70) | KIF11DNMT1 | |
| Hydrochloric Acid SCHEMBL29401160 | 0.85 | KIF11 (0.82) | KIF11DNMT1 | |
| Hydrochloric Acid SCHEMBL13736621 | 0.85 | KIF11 (0.82) | KIF11DNMT1 | |
| SCHEMBL7554607 | 0.85 | KIF11 (0.61) | KIF11DNMT1 | |
| SCHEMBL5996941 | 0.84 | KIF11 (0.65) | KIF11DNMT1 | |
| SCHEMBL29635035 | 0.84 | KIF11 (0.65) | KIF11DNMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016009341-A1 | THIOREDOXIN MIMETIC PRODRUGS AND USES THEREOF | RADIKAL THERAPEUTICS INC. (US) | 2016-01-21 | — | — | WO | disclosed |
| EP-0692982-B1 | RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS | DU PONT PHARM CO (US) | 2000-07-05 | — | — | EP | disclosed |
| EP-0995761-A2 | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders | Dupont Pharmaceuticals Company (US) | 2000-04-26 | — | — | EP | disclosed |
| US-6022523-A | NOVEL CYCLIC COMPOUNDS CONTAINING CARBOCYCLIC AND HETEROCYCLIC RING SYSTEMS | DUPONT PHARMACEUTICALS COMPANY (US) | 2000-02-08 | — | — | US | disclosed |
| US-5879657-A | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1999-03-09 | — | — | US | disclosed |
| EP-0692982-A4 | RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS | DU PONT MERCK PHARMA (US) | 1998-03-11 | — | — | EP | disclosed |
| EP-0575273-B1 | Crosslinkable derivatives of collagen, process for obtaining the same and their use in the preparation of biomaterials | FLAMEL TECH SA (FR) | 1997-12-03 | — | — | EP | disclosed |
| EP-0692982-A1 | RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-01-24 | — | — | EP | disclosed |
| US-5412076-A | Crosslinkable collagen derivatives, process for their production and their application to the preparation of biomaterials | FLAMEL TECHNOLOGIES (FR) | 1995-05-02 | — | — | US | disclosed |
| WO-1994022494-A1 | RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1994-10-13 | — | — | WO | disclosed |
| EP-0575273-A1 | Crosslinkable derivatives of collagen, process for obtaining the same and their use in the preparation of biomaterials | FLAMEL TECHNOLOGIES, Société Anonyme (FR) | 1993-12-22 | — | — | EP | disclosed |